Avance opens a centre for potency and cell-based assays
The Houston facility expands Avance Biosciences' capacity for functional and potency testing during therapy development. The reported capability is a product or workflow announcement, not independent proof of clinical diagnostic performance.
- Published by
- GEN — Genetic Engineering & Biotechnology News
- Evidence type
- Industry
GEN reports: The Houston facility expands Avance Biosciences' capacity for functional and potency testing during therapy development.
The reported capability is a product or workflow announcement, not independent proof of clinical diagnostic performance. Consult the linked GEN report for the source organisation’s full announcement.
Let's engineer the next delivery breakthrough together
We co-develop nanocarrier and biosensing programmes with pharma, biotech and academic groups — from target selection through GMP supply.
Prefer to talk it through? Book a 30-minute discovery call